Pharma Mar S.A.
Biopharmaceutical company developing oncology treatments from marine sources.
PHM | MC
Overview
Corporate Details
- ISIN(s):
- ES0169501022 (+1 more)
- LEI:
- 959800QWKZ45ZQC2AV58
- Country:
- Spain
- Address:
- Avenida de los Reyes 1 Polígono Industrial La Mina, 28770 Colmenar Viejo
- Website:
- https://pharmamar.com/en/
- Sector:
- Manufacturing
Description
Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-09-14 08:28 |
La Sociedad anuncia la aprobación de Zepzelca® (lurbinectedina) para el tratami…
|
Spanish | 128.0 KB | ||
| 2021-09-01 08:26 |
La Sociedad anuncia la aprobación de Zepzelca® (lurbinectedina) para el tratami…
|
Spanish | 121.2 KB | ||
| 2021-07-29 16:35 |
La Sociedad informa de cambios en la composición de la Comisión de Nombramiento…
|
Spanish | 35.3 KB | ||
| 2021-07-28 11:20 |
El COMP de la EMA, ha dado su opinión positiva para designación de Medicamento …
|
Spanish | 95.2 KB | ||
| 2021-07-13 11:21 |
La Sociedad anuncia la suscripción de un contrato de liquidez con JB Capital Ma…
|
Spanish | 40.1 KB | ||
| 2021-06-25 14:30 |
La Sociedad comunica la terminación del contrato de liquidez suscrito con fecha…
|
Spanish | 99.4 KB | ||
| 2021-05-05 08:23 |
La Sociedad publica información financiera correspondiente al primer trimestre …
|
Spanish | 701.2 KB | ||
| 2021-04-29 13:27 |
La Sociedad anuncia la obtención de autorización de la Agencia Española de Medi…
|
Spanish | 104.8 KB | ||
| 2021-04-23 08:24 |
La Sociedad anuncia que su socio, Specialised Therapeutics Asia, Pte. Ltd. (STA…
|
Spanish | 93.8 KB | ||
| 2021-04-16 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2021-04-15 14:35 |
La Sociedad comunica cambios en la composición de su Consejo de Administración …
|
Spanish | 42.8 KB | ||
| 2021-04-13 08:27 |
Axesor eleva la calificación crediticia a largo plazo de Pharma Mar.
|
Spanish | 31.8 KB | ||
| 2021-04-08 17:45 |
La Sociedad remite detalle de las operaciones del Contrato de Liquidez comprend…
|
Spanish | 99.8 KB | ||
| 2021-03-22 17:37 |
La Comisión Ejecutiva de Pharma Mar, S.A. ha decidido la ejecución del Plan de …
|
Spanish | 38.9 KB | ||
| 2021-03-18 17:36 |
La Sociedad remite anuncio complementario al de convocatoria de la Junta Genera…
|
Spanish | 38.7 KB |
Automate Your Workflow. Get a real-time feed of all Pharma Mar S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharma Mar S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharma Mar S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
